← Back to Search
Procedure
Auto-aligned OCT for Eye Disorders
Durham, NC
N/A
Waitlist Available
Led By Xi Chen, MD, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Group 1: Healthy adult volunteers must be able and willing to consent to study participation and be more than 18 years of age without known ocular issues other than refractive error
Must not have
Group 2: Adult patients in ophthalmology clinics must not have a health or eye condition that precludes eye examination or retinal imaging (such as corneal opacity or cataract)
Group 3: Pediatric participants in ophthalmology clinics must have a parent/legal guardian unwilling or unable to provide consent and must not have a health or eye condition that precludes eye examination or retinal imaging (such as corneal opacity or cataract)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 single imaging sessions at clinical visits over 2 years
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to test a new handheld device that can automatically align to take images of the retina in adult volunteers and patients of all ages in a clinic setting."
See full description
Who is the study for?
This trial is for both adults and children with various eye conditions such as Purtscher Retinopathy, optic nerve issues, neuro-ophthalmological disorders, glaucoma, and other retinal diseases. It aims to include volunteers who can undergo imaging with a new handheld device in a clinical setting.Check my eligibility
What is being tested?
The study is testing an advanced version of a handheld OCT (Optical Coherence Tomography) device that automatically aligns itself to capture images of the retina. This pilot study will assess its effectiveness in real-world clinic settings on adult and pediatric patients.See study design
What are the potential side effects?
Since this trial involves non-invasive imaging using an auto-aligned OCT device, there are minimal expected side effects. The primary concern may be discomfort from bright lights or sitting still during the imaging process.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 18, healthy, willing to participate, and have no eye problems except for needing glasses or contacts.
show original
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I don't have any health issues that prevent eye exams or imaging.
show original
Select...
My child can undergo an eye exam and does not have conditions like corneal opacity or cataract.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 4 single imaging sessions at clinical visits over 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 single imaging sessions at clinical visits over 2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of participants with abnormal retinal microanatomy
Retinal thickness (microns) at the fovea and surrounding optic nerve as measured by OCT analysis
Severity of abnormal retinal microanatomy
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Group 3: Pediatric patients in ophthalmology clinicsExperimental Treatment1 Intervention
Minor participants recruited from the patient population of Duke Eye Center undergoing clinical examination (n=10)
Group II: Group 2: Adult patients in ophthalmology clinicsExperimental Treatment1 Intervention
Adult participants recruited from the patient population of Duke Eye Center undergoing clinical examination (n=20)
Group III: Group 1: Healthy adult volunteersExperimental Treatment1 Intervention
Healthy adult volunteers recruited from the patient population, students or employees of Duke University or Duke Eye Center (n=20)
Find a Location
Closest Location:Duke University Eye Center· Durham, NC· 355 miles
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,494 Previous Clinical Trials
5,908,956 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,890 Previous Clinical Trials
8,050,650 Total Patients Enrolled
National Eye Institute (NEI)NIH
569 Previous Clinical Trials
1,319,503 Total Patients Enrolled
Xi Chen, MD, PhDPrincipal InvestigatorDuke University